ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025

Core Points - ImmuCell Corporation plans to report unaudited financial results for Q3 2025 on November 13, 2025, after market close [1][3] - A conference call is scheduled for November 14, 2025, at 9:00 AM ET to discuss the financial results [2] - The company anticipates no changes to the preliminary sales results disclosed on October 7, 2025 [3] - An updated Corporate Presentation slide deck will be available after market close on November 13, 2025 [4] Company Overview - ImmuCell Corporation focuses on developing scientifically proven products to enhance the health and productivity of dairy and beef cattle [5] - The company manufactures First Defense, which provides Immediate Immunity™ to newborn calves, and is developing Re-Tain, a treatment for subclinical mastitis in dairy cows [5]